➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Merck
Mallinckrodt
Express Scripts
Boehringer Ingelheim

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

LORAZEPAM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for lorazepam and what is the scope of freedom to operate?

Lorazepam is the generic ingredient in five branded drugs marketed by Akorn, Amneal Pharms, Lannett Co Inc, Lupin Ltd, Pharm Assoc, Hikma, Bedford, Dava Pharms Inc, Dr Reddys, Hospira, Intl Medication Sys, Mylan Asi, Watson Labs, West-ward Pharms Int, Bedford Labs, Roxane, Bausch, Quantum Pharmics, Am Therap, Anda Repository, Ani Pharms Inc, Aurolife Pharma Llc, Halsey, Leading Pharma Llc, Mutual Pharm, Mylan, Oxford Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Superpharm, Usl Pharma, and Warner Chilcott, and is included in sixty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for lorazepam. Thirty-six suppliers are listed for this compound.

Drug Prices for LORAZEPAM

See drug prices for LORAZEPAM

Drug Sales Revenue Trends for LORAZEPAM

See drug sales revenues for LORAZEPAM

Recent Clinical Trials for LORAZEPAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute on Drug Abuse (NIDA)Phase 2
InterveXion Therapeutics, LLCPhase 2
Jayasree BasivireddyPhase 3

See all LORAZEPAM clinical trials

Pharmacology for LORAZEPAM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for LORAZEPAM

US Patents and Regulatory Information for LORAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz LORAZEPAM lorazepam TABLET;ORAL 071194-001 Apr 15, 1988 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan Asi LORAZEPAM lorazepam INJECTABLE;INJECTION 200542-001 Apr 28, 2017 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Halsey LORAZEPAM lorazepam TABLET;ORAL 071434-001 Sep 1, 1987 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LORAZEPAM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-001 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
Hikma ATIVAN lorazepam INJECTABLE;INJECTION 018140-002 Approved Prior to Jan 1, 1982   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Harvard Business School
Moodys
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.